AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21593349 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) supplementation (50:50 mixture of trans 10, cis 12 and cis 9, trans 11 CLA)
Number of subjects: 27
Study 21593349 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) supplementation (c9, t11 isomer:c9, t11 CLA)
Number of subjects: 27
Study 21593349 — intervention group
Group type: COMPARATOR
Intervention: Safflower oil (control)
Number of subjects: 27
Study 21593349 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) supplementation
Number of subjects: 27
Study 19369098 — intervention group
Group type: EXPERIMENTAL
Intervention: Single‐cone ProTaper gutta‐percha with AH‐26
Number of subjects: 70
Study 19369098 — intervention group
Group type: COMPARATOR
Intervention: Lateral compaction technique with AH‐26
Number of subjects: 70
Study 19369098 — intervention group
Group type: EXPERIMENTAL
Intervention: Single‐cone ProTaper gutta‐percha with Apexit
Number of subjects: 70
Study 19369098 — intervention group
Group type: COMPARATOR
Intervention: Lateral compaction technique with Apexit
Number of subjects: 70
Study 19369098 — intervention group
Group type: EXPERIMENTAL
Intervention: Single‐cone ProTaper gutta‐percha with Sealite‐Ultra
Number of subjects: 70
Study 19369098 — intervention group
Group type: COMPARATOR
Intervention: Lateral compaction technique with Sealite‐Ultra
Number of subjects: 70
Study 16965910 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide and cisplatin (CP)
Number of subjects: 169
Study 15218999 — intervention group
Group type: EXPERIMENTAL
Intervention: BA+ICS (0.2 mg salbutamol t.i.d. and 0.2 mg budesonide t.i.d.)
Number of subjects: 54
Study 15218999 — intervention group
Group type: COMPARATOR
Intervention: BA+PL (placebo t.i.d.)
Number of subjects: 54
Study 15218999 — intervention group
Group type: EXPERIMENTAL
Intervention: BA+ICS
Number of subjects: 54
Study 15218999 — intervention group
Group type: COMPARATOR
Intervention: BA+PL
Number of subjects: 54
Study 10899363 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine (AMPH; 15 mg oral)
Number of subjects: 19
Study 10899363 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 9270499 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer antimicrobial agents (third- and fourth-generation cephalosporins, β-lactam, β-lactamase inhibitor combination agents, monobactams, carbapenems, macrolides, fluoroquinolones)
Number of subjects: 0
Study 9270499 — intervention group
Group type: COMPARATOR
Intervention: Older antimicrobial agents
Number of subjects: 0
Study 8112367 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 36
Study 3089942 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral penicillin V‐K (100,000 U/kg/day every 6 h)
Number of subjects: 39
Study 3089942 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 29329233 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolyzed whey-protein (30 kcal)
Number of subjects: 20
Study 29329233 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolyzed whey-protein (90 kcal)
Number of subjects: 20
Study 29329233 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolyzed whey-protein (180 kcal)
Number of subjects: 20
Study 29329233 — intervention group
Group type: COMPARATOR
Intervention: Saline control (0 kcal)
Number of subjects: 20
Study 29932415 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection (2 mL)
Number of subjects: 60
Study 29932415 — intervention group
Group type: COMPARATOR
Intervention: Procaine injection
Number of subjects: 60
Study 29932415 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection
Number of subjects: 60
Study 26149510 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD medications (stimulant or nonstimulant)
Number of subjects: 48
Study 26149510 — intervention group
Group type: COMPARATOR
Intervention: No ADHD medications (control group)
Number of subjects: 48
Study 23086673 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic intra-aortic balloon counterpulsation (IABC)
Number of subjects: 71
Study 23086673 — intervention group
Group type: COMPARATOR
Intervention: Conventional hypervolemic therapy (HT)
Number of subjects: 71
Study 21354549 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior preeclampsia
Number of subjects: 369
Study 21354549 — intervention group
Group type: COMPARATOR
Intervention: No prior preeclampsia
Number of subjects: 369
Study 18298238 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged abstainers
Number of subjects: 21
Study 18298238 — intervention group
Group type: COMPARATOR
Intervention: Nonabstainers
Number of subjects: 21
Study 16575034 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.05 mg x kg(‐1))
Number of subjects: 36
Study 16575034 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane (1.1% end‐tidal)
Number of subjects: 36
Study 16575034 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline (3 mg.kg(‐1))
Number of subjects: 36
Study 15198411 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg
Number of subjects: 160
Study 15198411 — intervention group
Group type: EXPERIMENTAL
Intervention: dexamethasone 8 mg
Number of subjects: 160
Study 15198411 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg plus dexamethasone 8 mg
Number of subjects: 160
Study 15198411 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 160
Study 15198411 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron with dexamethasone
Number of subjects: 160
Study 11108899 — intervention group
Group type: EXPERIMENTAL
Intervention: High trans diet (trans alpha-linolenic acid providing 0.6% of energy)
Number of subjects: 88
Study 11108899 — intervention group
Group type: COMPARATOR
Intervention: Low trans diet
Number of subjects: 88
Study 11108899 — intervention group
Group type: EXPERIMENTAL
Intervention: High trans diet
Number of subjects: 88
Study 7993004 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubed radial forearm free flap reconstruction with Blom‐Singer prosthesis
Number of subjects: 11
Study 7993004 — intervention group
Group type: COMPARATOR
Intervention: Standard pharyngeal closures
Number of subjects: 11
Study 3052571 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 45
Study 3052571 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple injections (MI)
Number of subjects: 45
Study 3052571 — intervention group
Group type: COMPARATOR
Intervention: Conventional insulin treatment (CIT)
Number of subjects: 45
Study 3052571 — intervention group
Group type: EXPERIMENTAL
Intervention: CSII and MI (combined outcome)
Number of subjects: 45
Study 3052571 — intervention group
Group type: EXPERIMENTAL
Intervention: CSII and MI (compared to non-cotton-wool spots)
Number of subjects: 45
Study 3052571 — intervention group
Group type: EXPERIMENTAL
Intervention: CSII and MI (intensified treatment)
Number of subjects: 45
Study 31122650 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-learning propranolol (40 mg)
Number of subjects: 75
Study 31122650 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-learning propranolol (40 mg)
Number of subjects: 75
Study 31122650 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-encoding propranolol (40 mg) in women
Number of subjects: 75
Study 31122650 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 31326732 — intervention group
Group type: EXPERIMENTAL
Intervention: Bi-parietal stimulation
Number of subjects: 11
Study 31326732 — intervention group
Group type: EXPERIMENTAL
Intervention: Bi-frontal stimulation
Number of subjects: 11
Study 31326732 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 11
Study 28207655 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-low radiation imaging (ULRI) with image enhancement
Number of subjects: 24
Study 28207655 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose C-arm fluoroscopy
Number of subjects: 24
Study 26387859 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper thoracic spine manipulation
Number of subjects: 32
Study 26387859 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 23624059 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor stress (CPS) during reconsolidation
Number of subjects: 0
Study 23624059 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral source of glucose (juice) during reconsolidation
Number of subjects: 0
Study 23624059 — intervention group
Group type: COMPARATOR
Intervention: Diet juice (control)
Number of subjects: 0
Study 21542913 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured group education based on psychological theories and current evidence
Number of subjects: 82
Study 21542913 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 82
Study 19023522 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin used in 26% of patients
Number of subjects: 624
Study 19023522 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational sessions and risk stratification guidelines
Number of subjects: 624
Study 17442032 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visiting programme by experienced home nurses (8 visits over 18 months)
Number of subjects: 160
Study 17442032 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visiting programme by experienced home nurses
Number of subjects: 160
Study 14996776 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg)
Number of subjects: 654
Study 14996776 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin (40 mg)
Number of subjects: 654
Study 11475557 — intervention group
Group type: COMPARATOR
Intervention: MIP-1 alpha in chronic bronchitis patients
Number of subjects: 40
Study 11475557 — intervention group
Group type: COMPARATOR
Intervention: MIP-1 beta in chronic obstructive pulmonary disease patients
Number of subjects: 40
Study 11475557 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of MIP-1 beta with eosinophils in chronic bronchitis
Number of subjects: 40
Study 9602592 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenon anaesthesia (MAC = 71%)
Number of subjects: 27
Study 9602592 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane anaesthesia (MAC = 2%)
Number of subjects: 27
Study 7594429 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of amlodipine and doxazosin (study A)
Number of subjects: 24
Study 7594429 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of amlodipine and enalapril (study B)
Number of subjects: 24
Study 7594429 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine alone
Number of subjects: 24
Study 7594429 — intervention group
Group type: COMPARATOR
Intervention: Doxazosin alone (study A)
Number of subjects: 24
Study 7594429 — intervention group
Group type: COMPARATOR
Intervention: Enalapril alone (study B)
Number of subjects: 24
Study 2253658 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide 20 mg injected intravenously
Number of subjects: 8
Study 2253658 — intervention group
Group type: COMPARATOR
Intervention: Captopril pretreatment
Number of subjects: 8
Study 2253658 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide
Number of subjects: 8
Study 7011279 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (1.0 g/day initially, increased to 1.6 g/day if less than 50% reduction in ulcer size)
Number of subjects: 14
Study 7011279 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (600 mg/day)
Number of subjects: 14
Study 7011279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 7011279 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (after stopping maintenance treatment)
Number of subjects: 14
Study 31418331 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Loss group (WL)
Number of subjects: 20
Study 31418331 — intervention group
Group type: COMPARATOR
Intervention: Weight Stable group (WS)
Number of subjects: 20
Study 30924166 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide 20 mg intravenously
Number of subjects: 80
Study 30924166 — intervention group
Group type: COMPARATOR
Intervention: Placebo intravenously
Number of subjects: 80
Study 28347540 — intervention group
Group type: EXPERIMENTAL
Intervention: Sivelestat administered perioperatively for 5 days
Number of subjects: 130
Study 28347540 — intervention group
Group type: COMPARATOR
Intervention: No medications administered (Control group)
Number of subjects: 130
Study 28347540 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative partial pressure oxygen level
Number of subjects: 130
Study 25864870 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D + omega-3 PUFA (30 µg vitamin D3, 3000 mg eicosapentaenoic acid, 3000 mg docosahexaenoic acid)
Number of subjects: 10
Study 25864870 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 25864870 — intervention group
Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 10
Study 22626630 — intervention group
Group type: EXPERIMENTAL
Intervention: Hilotherm(®) cooling face mask
Number of subjects: 32
Study 22626630 — intervention group
Group type: COMPARATOR
Intervention: Conventional cooling with cooling compresses
Number of subjects: 32
Study 21156702 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil and low-molecular-weight heparin
Number of subjects: 615
Study 21156702 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat retinal detachment surgery
Number of subjects: 615
Study 21156702 — intervention group
Group type: EXPERIMENTAL
Intervention: PVR
Number of subjects: 615
Study 19717506 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency sound wave therapy, 3-5 times a week for 30 minutes per session over 6 months
Number of subjects: 49
Study 19717506 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency sound wave therapy
Number of subjects: 49
Study 19717506 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 49
Study 17451140 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive drugs, specifically blockers of the renin-angiotensin axis
Number of subjects: 0
Study 15043563 — intervention group
Group type: EXPERIMENTAL
Intervention: WBC-reduced RBCs after implementation of ULR (T2)
Number of subjects: 2095
Study 15043563 — intervention group
Group type: COMPARATOR
Intervention: Non-WBC-reduced RBCs before implementation of ULR (T1)
Number of subjects: 2095
Study 11765303 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 0
Study 11765303 — intervention group
Group type: EXPERIMENTAL
Intervention: Dofetilide
Number of subjects: 0
Study 11765303 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 0
Study 11765303 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 9323820 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm continuous retrograde blood cardioplegia
Number of subjects: 29
Study 9323820 — intervention group
Group type: COMPARATOR
Intervention: Intermittent cold retrograde blood cardioplegia
Number of subjects: 29
Study 8313326 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative surgery plus radiation therapy
Number of subjects: 142
Study 8313326 — intervention group
Group type: COMPARATOR
Intervention: Mastectomy
Number of subjects: 142
Study 3046826 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam, 20 mg per day
Number of subjects: 252
Study 3046826 — intervention group
Group type: COMPARATOR
Intervention: Naproxen, 750 mg per day
Number of subjects: 252
Study 29687457 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT), 10-session manualized intervention
Number of subjects: 68
Study 29687457 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 68
Study 28063865 — intervention group
Group type: EXPERIMENTAL
Intervention: CSD SBML intervention
Number of subjects: 20
Study 25389641 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smoking
Number of subjects: 534
Study 25389641 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure
Number of subjects: 534
Study 25389641 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes mellitus
Number of subjects: 534
Study 25389641 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline AAA diameter
Number of subjects: 534
Study 23692516 — intervention group
Group type: EXPERIMENTAL
Intervention: ICA-105665 100 mg
Number of subjects: 17
Study 23692516 — intervention group
Group type: EXPERIMENTAL
Intervention: ICA-105665 400 mg
Number of subjects: 17
Study 23692516 — intervention group
Group type: EXPERIMENTAL
Intervention: ICA-105665 500 mg
Number of subjects: 17
Study 23692516 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 20697044 — intervention group
Group type: EXPERIMENTAL
Intervention: 450 or 900 mg of idebenone per day (n = 22)
Number of subjects: 70
Study 20697044 — intervention group
Group type: EXPERIMENTAL
Intervention: 1350 or 2250 mg of idebenone per day (n = 24)
Number of subjects: 70
Study 20697044 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 24)
Number of subjects: 70
Study 18054934 — intervention group
Group type: EXPERIMENTAL
Intervention: ASA+Pred (n = 97)
Number of subjects: 395
Study 18054934 — intervention group
Group type: COMPARATOR
Intervention: Control (n = 298)
Number of subjects: 395
Study 16642604 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Baliao and Huiyang (BL 35)
Number of subjects: 84
Study 16642604 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture at routinely selected acupoints (Control)
Number of subjects: 84
Study 12855298 — intervention group
Group type: EXPERIMENTAL
Intervention: Information reduction tasks (digit reversal, digit classification, counting backward by 3s)
Number of subjects: 0
Study 10807098 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronan injections
Number of subjects: 46
Study 10807098 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 46
Study 9387366 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at Zusanli (ST 36) and Neiguan (PC 6) combined with epidural anesthesia of small dosage (group A)
Number of subjects: 48
Study 9387366 — intervention group
Group type: COMPARATOR
Intervention: Simple epidural anesthesia of small dosage (group B)
Number of subjects: 48
Study 15374380 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine (200 mg for 1 h)
Number of subjects: 20
Study 15374380 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 3881014 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 1800 mg/day
Number of subjects: 20
Study 3881014 — intervention group
Group type: COMPARATOR
Intervention: Sucralfate 8 g/day
Number of subjects: 20
Study 30585829 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal replacement therapy
Number of subjects: 1124
Study 30585829 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet decrease following renal replacement therapy initiation
Number of subjects: 1124
Study 30585829 — intervention group
Group type: COMPARATOR
Intervention: Continuous renal replacement therapy
Number of subjects: 1124
Study 28456425 — intervention group
Group type: EXPERIMENTAL
Intervention: Spoken information supported by a leaflet
Number of subjects: 178
Study 28456425 — intervention group
Group type: COMPARATOR
Intervention: Spoken information
Number of subjects: 178
Study 26197029 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg of terbutaline (TER)
Number of subjects: 9
Study 26197029 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 9
Study 24988121 — intervention group
Group type: EXPERIMENTAL
Intervention: lisdexamfetamine dimesylate (Vyvanse)
Number of subjects: 22
Study 24988121 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 23080528 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Body‐Mind‐Spirit (I‐BMS) intervention
Number of subjects: 339
Study 23080528 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 339
Study 19281718 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention to treat analysis
Number of subjects: 0
Study 19281718 — intervention group
Group type: COMPARATOR
Intervention: Informative censoring
Number of subjects: 0
Study 17227746 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic treatment (optimal medication identified after screening phase)
Number of subjects: 83
Study 17227746 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic treatment (optimal medication identified)
Number of subjects: 83
Study 15176988 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg daily plus elemental calcium 500 mg daily
Number of subjects: 55
Study 15176988 — intervention group
Group type: COMPARATOR
Intervention: Calcium 500 mg daily alone
Number of subjects: 55
Study 12351277 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistive heating blankets
Number of subjects: 24
Study 12351277 — intervention group
Group type: COMPARATOR
Intervention: Normal wool blankets
Number of subjects: 24
Study 9839093 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose (25-100 mg t.i.d.)
Number of subjects: 0
Study 9839093 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8208469 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin prophylaxis
Number of subjects: 38
Study 8208469 — intervention group
Group type: COMPARATOR
Intervention: Control (no antibiotic prophylaxis)
Number of subjects: 38
Study 2543048 — intervention group
Group type: EXPERIMENTAL
Intervention: New less toxic treatment
Number of subjects: 0
Study 2543048 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study 29895740 — intervention group
Group type: EXPERIMENTAL
Intervention: AAR + counseling
Number of subjects: 327
Study 29895740 — intervention group
Group type: COMPARATOR
Intervention: AAR + control (nutrition education attention control)
Number of subjects: 327
Study 27440796 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyester containing herbal extract dressing
Number of subjects: 0
Study 27440796 — intervention group
Group type: COMPARATOR
Intervention: Commercially available and common use dressings
Number of subjects: 0
Study 24075291 — intervention group
Group type: EXPERIMENTAL
Intervention: Quick Mild Cognitive Impairment (Qmci) screen
Number of subjects: 406